RxNorm Names
LORATADINE tablet
[Chain Drug Marketing Association Inc.]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4edf5b1-398d-405a-8a42-76044b31ebb7| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | Abbreviated New Drug Application |
USES
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- itchy, watery eyes
- sneezing
- itching of the nose or throat
WARNINGS
Ask a doctor before use if you have
Liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product
Do not take more than directed. Taking more than directed may cause drowsiness.
DIRECTIONS
| adults and children 6 years and over | 1 tablet daily; not more than 1 tablet in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
OTHER INFORMATION
- store between 20 and 25° C (68 and 77° F)
- protect from excessive moisture
- TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
| LORATADINE
loratadine tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
| Labeler - Chain Drug Marketing Association Inc. (011920774) |
| Registrant - Ranbaxy Pharmaceuticals Inc. (937890044) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Ohm Laboratories Inc. | 051565745 | manufacture(63868-151) | |
Revised: 09/2012
Document Id: 4d81a3ac-7d56-4d16-b0d6-32c1122004e3
Set id: b4edf5b1-398d-405a-8a42-76044b31ebb7
Version: 1
Effective Time: 20120913
Chain Drug Marketing Association Inc.
Review RxNorm Normal Forms